SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending as investors and the online community debate a campaign proposal to provide a significant dividend payment to every U.S. adult if Republicans retain control of Congress. Discussion is polarized, with participants arguing over the fiscal feasibility of the plan, its potential impact on the national debt, and whether it serves as a legitimate economic stimulus or an election-related bribe.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is facing downward pressure amid criticism from traders over the company's recent exclusion from the S&P 100 and concerns regarding its turnaround strategy and management. While some investors see the stock as a long-term value opportunity at current levels, others are bearish, citing declining market share and brand sentiment as reasons for further potential downside.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple shares experienced high volatility following the product launch of its new iPhone 18 lineup and the company's first foldable device, the iPhone Duo. While the premium pricing and product innovation sparked intense debate among traders regarding consumer demand and market competition, retail sentiment remains largely bullish with expectations for strong adoption.

AeroVironment, Inc. is a defense technology company delivering integrated capabilities across air, land, sea, space, and cyber. The company develops and deploys autonomous systems, loitering munitions, counter-UAS technologies, space-based platforms, directed energy systems, and cyber and electronic warfare capabilities-built to meet the mission needs of today’s warfighter and tomorrow’s conflicts. At the core of these technologies lies AV_Halo, a modular, mission-ready suite of AI-powered software tools that empowers warfighters and enables full-battlefield dominance: detect, decide, deliver. With a national manufacturing footprint and a deep innovation pipeline, AV delivers proven systems and future-defining capabilities at speed, scale, and operational relevance. The company was founded by Paul B. MacCready, Jr. in July 1971 and is headquartered in Arlington, VA.

AeroVironment Inc.

AeroVironment shares are receiving attention following a record fiscal first-quarter earnings report that featured a revenue beat, high book-to-bill ratios, and a record funded backlog. While some traders express frustration with the stock's recent price performance despite contract wins, others highlight the growth potential of its high-energy laser and drone defense systems.

American Eagle Outfitters, Inc. operates retail stores and e-commerce channels offering apparel, accessories, and personal care products under the American Eagle and Aerie brands. It also operates the OFFL/NE by Aerie, Todd Snyder, and Unsubscribed brands. The firm operates stores in the United States, Canada, and Mexico and sells its products through international license partners. The company was founded in 1977 and is headquartered in Pittsburgh, PA.

American Eagle Outfitters Inc.

American Eagle Outfitters, Inc.

AEO stock dropped following its quarterly report as investors discounted the earnings beat due to a one-time tariff refund, while the market focused on disappointing results from the namesake American Eagle brand. The community remains divided, with some traders expressing frustration over the sell-off and potential manipulation, while others view the pullback as a buying opportunity given the brand's holiday outlook.

Biohaven Ltd. is a global clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of therapies for people with neurological and neuropsychiatric diseases. The company was founded on May 2, 2022 and is headquartered in New Haven, CT.

Biohaven Ltd

Biohaven Pharmaceutical Holding Company Ltd

Biohaven shares are reacting to the company's disclosure that the FDA has ordered a pause in enrollment for the BHV7000-303 epilepsy study, though dosing continues and the data readout remains on schedule for late 2026. While some investors view the pullback as a buying opportunity, others are expressing concern over the regulatory setback.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD shares are gaining momentum as traders react to positive commentary from CFO Jean Hu regarding an expanded total addressable market for AI chips and robust shipment projections through 2027. While community sentiment is largely bullish on growth prospects, some traders remain skeptical of current valuations, leading to debates over potential profit-taking and volatility.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

The community is debating the potential economic impact of a proposed dividend payment to voters, while reacting to rising oil prices and Treasury yields that are pressuring equities ahead of key inflation data. Sentiment is divided between those bracing for a potential downturn and others skeptical of political promises.

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. Its products include Gvoke, Keveyis, and Recorlev. Gvoke is a ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

Xeris Biopharma Holdings Inc

Xeris Biopharma is trending following a recent event detailing the clinical and commercial roadmap for its pipeline asset, XP-8121, which includes a Phase 3 trial initiation anticipated by year-end and a launch projected for 2030. While some traders expressed disappointment over the long-term timeline and are concerned about near-term expenses, others view the company's established growth in Recorlev and the multibillion-dollar potential of XP-8121 as strong long-term catalysts.

Cybin, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.

Helus Pharma Inc.

Helus Pharma is trending primarily due to positive community sentiment surrounding its Phase 3 APPROACH trial for HLP003, with investors highlighting the completion of enrollment ahead of schedule and the company's $50 million underwritten offering as key developments. Traders are also speculating on potential acquisition interest, drawing comparisons to recent M&A activity in the broader psychedelic neuropsychiatry sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

12 Health Care Stocks Moving In Tuesday's Intraday Session

Gainers

Creative Medical Tech (NASDAQ:CELZ) stock moved upwards by 242.5% to $2.77 during Tuesday's regular session. The market value of their outstanding shares is at $2.9 million.
Cuprina Holdings (Cayman)read more...

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Gainers

Abivax (NASDAQ:ABVX) shares increased by 36.0% to $130.74 during Tuesday's pre-market session. The company's market cap stands at $7.6 billion.
Cuprina Holdings (Cayman) (NASDAQ:CUPR) shares movedread more...

Cuprina Holdings Falls 22% After 112% Rally  Here's Why CUPR Stock Is Trending

Cuprina stock surged 112% after FDA clearance for MEDIFLY Maggots before falling sharply in after-hours trading.read more...

Why Did CUPR Stock Surge Over 150% Today? 

Equity

Cuprina Holdings said its medicinal larvae product, MEDIFLY Maggots, has been approved by the FDA to treat non-healing injuries, such as diabetic foot ulcers.

Why Traders Are Piling into These Emerging Healthcare Names as New Catalysts Emerge

Biotechnology and healthcare innovation dominated investor conversations today as multiple companies delivered meaningful corporate, clinical, regulatory, and commercialization updates. From artificial intelligence-powered drug discovery platforms to neuro-oncology, regenerative medicine, wound care technologies, and autoimmune disease therapies, investors focused on companies that could potentially benefit from major industry trends while advancing important milestones of their own. $CUPR, $HYFT, $NTHI, $RGNT, $GELS, $SABS

Why Cuprina Holdings Stock Is Surging Today?

Cuprina stock jumps after regaining Nasdaq compliance, easing delisting concerns and keeping its shares listed on Nasdaq.read more...

Rosen Law Firm Encourages Cuprina Holdings (Cayman) Ltd. Investors to Inquire About Securities Class Action Investigation CUPR

Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Cuprina Holdings (Cayman) Ltd. (NASDAQ: CUPR) resulting...

Micro-Cap Cuprina Stock Soars Nearly 300% Premarket: What’s Behind The Surge?

The Singapore-headquartered medical devices company announced the previous day that it had secured exclusive rights to a groundbreaking medical waste recycling technology.


Cuprina Holdings (Cayman) Ltd. engages in the manufacturing, sale, and supply of medical devices to manage and accelerate healing and closure of chronic wounds. Its products include nature-based bioactive, in the form of advanced wound dressings, derived from sustainable sources. The company was founded by Carl Marc Baptista on August 28, 2019 and is headquartered in Singapore.

Cuprina Holdings (Cayman) Ltd. - Ordinary Shares - Class A

Neutral Sentiment

Yes, day one

Yes, but I'll wait for reviews

No, too expensive

No, not interested in a foldable

Apple unveiled its first foldable iPhone, reportedly called the iPhone Duo, at its September 9 event, with pricing starting at $2,000 for the 256GB model. Will you buy the $2,000 iPhone Duo? Vote and explain your reasoning in the comments.

Apple ($AAPL) just unveiled its first foldable iPhone, the iPhone Duo, starting at $2,000. Will you buy it?

Stocktwits

) just unveiled its first foldable iPhone, the iPhone Duo, starting at $2,000. Will you buy it?

Current Price	$2.91
Prev Close	$3.12
Open	$3.18
Dividend Yield	0.00%
50-Day Moving Average	$3.60
Beta	3.94
Avg. Volume	21,066.68
PE Ratio	-2.18

52-Week High	$14.80
52-Week Low	$1.76
Market Capitalization	$2.87M
EPS (Annual)	-$1.33
Price to Book	1.98
Revenue Per Employee	$3,818.60

Feed

News

Sentiment

Fundamentals

Info

CUPR Fundamentals